This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Cansfield,_J.E.
There is no page with the exact title "Cansfield,_J.E.". The search results for "Cansfield,_J.E." are displayed below. You can create a page titled Cansfield,_J.E. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Cansfield A (42 bytes)
1: List of pages with the keyword Cansfield A - Category:Cansfield, J E (45 bytes)
1: List of pages with the keyword Cansfield, J E - Category:Cansfield, A D (45 bytes)
1: List of pages with the keyword Cansfield, A D - Category:Cansfield, A (43 bytes)
1: List of pages with the keyword Cansfield, A - Category:Cansfield J (42 bytes)
1: List of pages with the keyword Cansfield J - Category:Cansfield, J (43 bytes)
1: List of pages with the keyword Cansfield, J - Category:Cansfield AD (43 bytes)
1: List of pages with the keyword Cansfield AD - Category:Cansfield JE (43 bytes)
1: List of pages with the keyword Cansfield JE
Page text matches
- 2uwd (6,656 bytes)
2: ...etic, potent resorcinylic pyrazole, isoxazole amide analogs==
3: ...uwd]], [[Resolution|resolution]] 1.90Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2UWD FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr>
7: ... <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> - 2c69 (6,514 bytes)
2: ...he human CDK2 complexed with the triazolopyrimidine inhibitor==
3: ...c69]], [[Resolution|resolution]] 2.10Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2C69 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1Å</td></tr>
7: ...[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-AMINE'>CT8</scene></td></tr> - 2c6l (6,489 bytes)
2: ...he human CDK2 complexed with the triazolopyrimidine inhibitor==
3: ...c6l]], [[Resolution|resolution]] 2.30Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2C6L FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr>
7: ...PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE'>DT4</scene></td></tr> - 2c6m (6,478 bytes)
2: ...he human CDK2 complexed with the triazolopyrimidine inhibitor==
3: ...c6m]], [[Resolution|resolution]] 1.90Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2C6M FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr>
7: ...PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE'>DT5</scene></td></tr> - 2c6i (6,482 bytes)
2: ...he human CDK2 complexed with the triazolopyrimidine inhibitor==
3: ...c6i]], [[Resolution|resolution]] 1.80Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2C6I FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.8Å</td></tr>
7: ...PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE'>DT1</scene></td></tr> - 2c6k (6,480 bytes)
2: ...he human CDK2 complexed with the triazolopyrimidine inhibitor==
3: ...c6k]], [[Resolution|resolution]] 1.90Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2C6K FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr>
7: ...PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE'>DT2</scene></td></tr> - 2c68 (6,508 bytes)
2: ...he human CDK2 complexed with the triazolopyrimidine inhibitor==
3: ...c68]], [[Resolution|resolution]] 1.95Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2C68 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.95Å</td></tr>
7: ...DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE'>CT6</scene></td></tr> - 2c6o (6,447 bytes)
2: ...he human CDK2 complexed with the triazolopyrimidine inhibitor==
3: ...c6o]], [[Resolution|resolution]] 2.10Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2C6O FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1Å</td></tr>
7: ...LMETHOXY-2-(4-SULPHAMOYLANILINO)+PURINE'>4SP</scene></td></tr> - 2c6t (6,584 bytes)
2: ...he human CDK2 complexed with the triazolopyrimidine inhibitor==
3: ...c6t]], [[Resolution|resolution]] 2.61Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2C6T FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.61Å</td></tr>
7: ...ne name='pdbligand=TPO:PHOSPHOTHREONINE'>TPO</scene></td></tr> - 2bsm (4,397 bytes)
2: ...aperone Hsp90 discovered through structure-based design==
3: ...bsm]], [[Resolution|resolution]] 2.05Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2BSM FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.05Å</td></tr>
7: ...ETHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE'>BSM</scene></td></tr> - 2bt0 (4,399 bytes)
2: ...aperone Hsp90 discovered through structure-based design==
3: ...bt0]], [[Resolution|resolution]] 1.90Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2BT0 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr>
7: ...H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL'>CT5</scene></td></tr> - 1y8y (6,791 bytes)
2: ...man CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor==
3: ...y8y]], [[Resolution|resolution]] 2.00Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1Y8Y FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.996Å</td></tr>
7: ...IN-7-YL)-(4-METHANESULFONYLPHENYL)AMINE'>CT7</scene></td></tr> - 1y91 (6,833 bytes)
2: ...man CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor==
3: ...y91]], [[Resolution|resolution]] 2.15Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=1Y91 FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.15Å</td></tr>
7: ...YLAMINO]-N,N-DIMETHYLBENZENESULFONAMIDE'>CT9</scene></td></tr> - 2vci (5,862 bytes)
2: ...ntial Therapeutic Agents for the Treatment of Cancer==
3: ...vci]], [[Resolution|resolution]] 2.00Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2VCI FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr>
7: ...YLMETHYL)PHENYL]ISOXAZOLE-3-CARBOXAMIDE'>2GJ</scene></td></tr> - 2vcj (5,855 bytes)
2: ...ntial Therapeutic Agents for the Treatment of Cancer==
3: ...vcj]], [[Resolution|resolution]] 2.50Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=2VCJ FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5Å</td></tr>
7: ...YLMETHYL)PHENYL]ISOXAZOLE-3-CARBOXAMIDE'>2EQ</scene></td></tr> - 4aof (6,390 bytes)
2: ...ay platform reveals regulation of Th17 cell differentiation by PI3Kgamma==
3: ...aof]], [[Resolution|resolution]] 3.30Å' scene=''>
5: ...://proteopedia.org/fgij/fg.htm?mol=4AOF FirstGlance]. <br>
6: ..." id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.3Å</td></tr>
7: ...]TRIAZOLO[1,5-A]PYRIDIN-2-YL]ETHANAMIDE'>7L0</scene></td></tr> - Category:Cansfield A (42 bytes)
1: List of pages with the keyword Cansfield A - Category:Cansfield, J E (45 bytes)
1: List of pages with the keyword Cansfield, J E - Category:Cansfield, A D (45 bytes)
1: List of pages with the keyword Cansfield, A D - Category:Cansfield, A (43 bytes)
1: List of pages with the keyword Cansfield, A
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
